Caso
Monovisão com SMILE
Um tratamento eficaz e seguro para pacientes com ametropia e presbiopia
9 setembro 2019
· 2 MIN. LEITURA
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.100.100.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg"})
Autor
Jakob Siedlecki, MD
Residente em oftalmologia, Ludwig-Maximilians-University of Munich, Munique, Alemanha
RESUMO
Estudo de caso da monovisão com SMILE
Este caso apresenta o SMILE como uma boa opção de tratamento para um paciente com ametropia e presbiopia que deseja a independência dos óculos para trabalhar com o computador e praticar atividades de lazer, como esportes aquáticos.
O caso confirma que o SMILE:
- É um tratamento eficaz e seguro
- É uma boa alternativa à cirurgia refrativa da córnea com minimonovisão
- É uma solução para pacientes com ametropia e presbiopia e um cristalino nítido
- Proporciona independência dos óculos para a maioria das atividades diárias.
![Pré-visualizar imagem de]({"max":"/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/pdf/jakob-siedlecki-smile-monovision.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Baixar")